These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 18201873)
1. Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp. Roveta S; Marchese A; Schito GC Int J Antimicrob Agents; 2008 Apr; 31(4):321-8. PubMed ID: 18201873 [TBL] [Abstract][Full Text] [Related]
2. A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms. Bauer J; Siala W; Tulkens PM; Van Bambeke F Antimicrob Agents Chemother; 2013 Jun; 57(6):2726-37. PubMed ID: 23571532 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus epidermidis. Domínguez-Herrera J; Docobo-Pérez F; López-Rojas R; Pichardo C; Ruiz-Valderas R; Lepe JA; Pachón J Antimicrob Agents Chemother; 2012 Feb; 56(2):613-7. PubMed ID: 22123684 [TBL] [Abstract][Full Text] [Related]
4. [In vitro effect of vancomycin and daptomycin on biofilm formation of coagulase-negative staphylococci strains]. Öcal DN; Dolapçı İ; Gençtürk Z; Tekeli A Mikrobiyol Bul; 2017 Jul; 51(3):220-235. PubMed ID: 28929959 [TBL] [Abstract][Full Text] [Related]
5. Effects of demethylfruticuline A and fruticuline A from Salvia corrugata Vahl. on biofilm production in vitro by multiresistant strains of Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis. Schito AM; Piatti G; Stauder M; Bisio A; Giacomelli E; Romussi G; Pruzzo C Int J Antimicrob Agents; 2011 Feb; 37(2):129-34. PubMed ID: 21163629 [TBL] [Abstract][Full Text] [Related]
6. Activity of daptomycin- and vancomycin-loaded poly-epsilon-caprolactone microparticles against mature staphylococcal biofilms. Ferreira IS; Bettencourt AF; Gonçalves LM; Kasper S; Bétrisey B; Kikhney J; Moter A; Trampuz A; Almeida AJ Int J Nanomedicine; 2015; 10():4351-66. PubMed ID: 26185439 [TBL] [Abstract][Full Text] [Related]
7. Zheng JX; Tu HP; Sun X; Xu GJ; Chen JW; Deng QW; Yu ZJ; Qu D J Med Microbiol; 2020 Jan; 69(1):120-131. PubMed ID: 31916929 [No Abstract] [Full Text] [Related]
8. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains. Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759 [TBL] [Abstract][Full Text] [Related]
9. Observed Antagonistic Effect of Linezolid on Daptomycin or Vancomycin Activity against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic Model. Luther MK; LaPlante KL Antimicrob Agents Chemother; 2015 Dec; 59(12):7790-4. PubMed ID: 26369963 [TBL] [Abstract][Full Text] [Related]
12. Methicillin resistance and biofilm production in clinical isolates of Staphylococcus aureus and coagulase-negative Staphylococcus in México. García A; Martínez C; Juárez RI; Téllez R; Paredes MA; Herrera MDR; Giono S Biomedica; 2019 Sep; 39(3):513-523. PubMed ID: 31584765 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model. Barber KE; Smith JR; Ireland CE; Boles BR; Rose WE; Rybak MJ Antimicrob Agents Chemother; 2015 Aug; 59(8):4497-503. PubMed ID: 25987623 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model. LaPlante KL; Mermel LA Nephrol Dial Transplant; 2007 Aug; 22(8):2239-46. PubMed ID: 17403700 [TBL] [Abstract][Full Text] [Related]
15. In vitro activity of gallium maltolate against Staphylococci in logarithmic, stationary, and biofilm growth phases: comparison of conventional and calorimetric susceptibility testing methods. Baldoni D; Steinhuber A; Zimmerli W; Trampuz A Antimicrob Agents Chemother; 2010 Jan; 54(1):157-63. PubMed ID: 19805560 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of daptomycin, linezolid and rifampicin on Staphylococcus epidermidis biofilms. Leite B; Gomes F; Teixeira P; Souza C; Pizzolitto E; Oliveira R Curr Microbiol; 2011 Sep; 63(3):313-7. PubMed ID: 21761219 [TBL] [Abstract][Full Text] [Related]
17. Activity of bone cement loaded with daptomycin alone or in combination with gentamicin or PEG600 against Staphylococcus epidermidis biofilms. Peñalba Arias P; Furustrand Tafin U; Bétrisey B; Vogt S; Trampuz A; Borens O Injury; 2015 Feb; 46(2):249-53. PubMed ID: 25498330 [TBL] [Abstract][Full Text] [Related]
18. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models. Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162 [TBL] [Abstract][Full Text] [Related]
19. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium. Jevitt LA; Smith AJ; Williams PP; Raney PM; McGowan JE; Tenover FC Microb Drug Resist; 2003; 9(4):389-93. PubMed ID: 15000746 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the antibiotic activities of Daptomycin, Vancomycin, and the investigational Fluoroquinolone Delafloxacin against biofilms from Staphylococcus aureus clinical isolates. Siala W; Mingeot-Leclercq MP; Tulkens PM; Hallin M; Denis O; Van Bambeke F Antimicrob Agents Chemother; 2014 Nov; 58(11):6385-97. PubMed ID: 25114142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]